Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

jan_rehwinkel

Jan Rehwinkel, a Group leader in HIU,  has recently been awarded a Lister Institute Research Prize Fellowship to study “Z-RNA and Z-DNA: Novel Inducers of Antiviral Immunity”.  Jan says “In addition to the well-known B- and A-form, double-stranded DNA and RNA can also adopt the so-called Z-conformation. Z-DNA and Z-RNA are characterised by a left-handed double helix, the absence of major grooves and a zig-zag arrangement of the phosphodiester backbone (hence the name, Z-DNA/RNA). Physiological functions of Z-DNA and Z-RNA are incompletely understood. A clue to their potential biological roles is the observation that Z-alpha and Z-beta domains, which specifically bind to Z-DNA and Z-RNA, are found in four proteins that are all involved in innate antiviral immunity. This suggests an important role of Z-DNA and/or Z-RNA in innate antiviral immune responses.  We hypothesize that nucleic acids in Z-conformation are generated specifically in virus-infected cells and are a novel pathogen-associated molecular pattern (PAMP) detected by proteins containing Z-alpha and Z-beta domains. This award will allow us to test this idea for ZBP1 (Z-DNA binding protein 1).”

Similar stories

Beyond Boundaries at the Oxford Imaging Symposium

Held on 29th September 2022, the symposium brought together researchers from across the world to present the latest applications of advanced imaging.

Anjali Kusumbe receives the RMS Life Sciences Medal

The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.

Fundraising for award in memory of Dr Ling Felce

The Ling Felce award will promote cross-disciplinary excellence in bioinformatics.

Study of T-cell receptor activation leads to surprising discovery

A study from Davis Group is the first to describe the structure of the T-cell receptor when bound to an activating ligand. The findings shed light on an important trigger in the immune system, and suggest a completely new process by which cell receptors can be activated.